All Stories

  1. 5H7c: A rabbit monoclonal antibody detecting ferroptotic cells
  2. Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
  3. Frugal engineering-inspired wearable augmented reality goggle system enables fluorescence-guided cancer surgery
  4. Development of New CD38 Targeted Peptides for Cancer Imaging
  5. Induction of complementary immunogenic necroptosis and apoptosis cell death pathways inhibits cancer metastasis and relapse
  6. Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting
  7. Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages
  8. Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases
  9. Low-cost augmented reality goggles enable precision fluorescence-guided cancer surgery
  10. Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
  11. Endogenous Cyclin D1 Promotes the Rate of Onset and Magnitude of Mitogenic Signaling via Akt1 Ser473 Phosphorylation
  12. S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice
  13. Gold nanoparticle-enhanced X-ray microtomography of the rodent reveals region-specific cerebrospinal fluid circulation in the brain
  14. Global health open-source goggles for fluorescence-guided surgery
  15. Breast cancer mutations HER2V777Land PIK3CAH1047Ractivate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance
  16. Quantitative tumor depth determination using dual wavelength excitation fluorescence
  17. First-in-Humans Evaluation of Safety and Dosimetry of64Cu-LLP2A for PET Imaging
  18. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer
  19. Analysis of Stable Chelate-free Gadolinium Loaded Titanium Dioxide Nanoparticles for MRI-Guided Radionuclide Stimulated Cancer Treatment
  20. Activation of nano-photosensitizers by Y-90 microspheres to enhance oxidative stress and cell death in hepatocellular carcinoma
  21. Global health open-source goggles for fluorescence-guided surgery
  22. Early Expression of MMP-9 Predicts Recovery of Tibialis Anterior after Sciatic Nerve Crush Injury
  23. MITI minimum information guidelines for highly multiplexed tissue images
  24. Side-chain modification of collagen-targeting peptide prevents dye aggregation for improved molecular imaging of arthritic joints
  25. Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy
  26. Preface
  27. Copper‐Catalyzed Covalent Dimerization of Near‐Infrared Fluorescent Cyanine Dyes: Synergistic Enhancement of Photoacoustic Signals for Molecular Imaging of Tumors
  28. Global cerebrospinal fluid circulation mapping using gold nanoparticle enhanced X-ray microtomography reveals region-specific brain and spinal cord CSF pathways
  29. Inactivation of multidrug‐resistant bacteria and bacterial spores and generation of high‐potency bacterial vaccines using ultrashort pulsed lasers
  30. Copper‐Catalyzed Covalent Dimerization of Near‐Infrared Fluorescent Cyanine Dyes: Synergistic Enhancement of Photoacoustic Signals for Molecular Imaging of Tumors
  31. Non-invasive monitoring of arthritis treatment response via targeting of tyrosine-phosphorylated annexin A2 in chondrocytes
  32. Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment
  33. In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET
  34. Nanoparticle T cell engagers for the treatment of acute myeloid leukemia
  35. In Vivo Quantitative Assessment of Therapeutic Response to Bortezomib Therapy in Disseminated Animal Models of Multiple Myeloma With [18F]FDG and [64Cu]LLP2A PET
  36. Fiber endface photoacoustic generator for quantitative photoacoustic tomography
  37. Calcium carbonate nanoparticles stimulate cancer cell reprogramming to suppress tumor growth and invasion in an organ-on-a-chip system
  38. Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases
  39. Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy
  40. Spatial drivers and pre-cancer populations collaborate with the microenvironment in untreated and chemo-resistant pancreatic cancer
  41. A highly sensitive strategy to detect dying cancer cells
  42. Orthogonal targeting of osteoclasts and myeloma cells for radionuclide stimulated dynamic therapy induces multidimensional cell death pathways
  43. Preface
  44. Calcium Carbonate Nanoparticles Stimulate Cancer Cell Reprogramming to Suppress Tumor Growth and Invasion in an Organ-on-a-chip System
  45. Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
  46. Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma
  47. The membrane-associated form of cyclin D1 enhances cellular invasion
  48. Endogenous Cyclin D1 Promotes the Rate of Onset and Magnitude of Mitogenic Signaling via Akt1 Ser473 Phosphorylation
  49. Photoacoustic laser effects in live mouse blastocysts: pilot safety studies of DNA damage from photoacoustic imaging doses
  50. Focal dynamic thermal imaging for label-free high-resolution characterization of materials and tissue heterogeneity
  51. Reduced Nhe1 (Na + -H + Exchanger-1) Function Protects ApoE-Deficient Mice From Ang II (Angiotensin II)–Induced Abdominal Aortic Aneurysms
  52. Head‐Mounted Devices for Noninvasive Cancer Imaging and Intraoperative Image‐Guided Surgery
  53. Ultrabright fluorescent nanoscale labels for the femtomolar detection of analytes with standard bioassays
  54. Repurposing Molecular Imaging and Sensing for Cancer Image–Guided Surgery
  55. The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
  56. Osteotropic Radiolabeled Nanophotosensitizer for Imaging and Treating Multiple Myeloma
  57. Selective imaging of solid tumours via the calcium-dependent high-affinity binding of a cyclic octapeptide to phosphorylated Annexin A2
  58. Intracranial glioma xenograft model rapidly reestablishes blood–brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents
  59. Preface
  60. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
  61. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum
  62. Effects of core titanium crystal dimension and crystal phase on ROS generation and tumour accumulation of transferrin coated titanium dioxide nanoaggregates
  63. Fluorescence lifetime imaging reveals heterogeneous functional distribution of eGFP expressed in Xenopus oocytes
  64. Trending: Radioactive and Fluorescent Bimodal/Hybrid Tracers as Multiplexing Solutions for Surgical Guidance
  65. Does the Impact Factor of a Journal Define the Value of Individual Papers?
  66. Na+-H+ exchanger 1 determines atherosclerotic lesion acidification and promotes atherogenesis
  67. Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapy
  68. Trafficking of a Single Photosensitizing Molecule to Different Intracellular Organelles Demonstrates Effective Hydroxyl Radical-Mediated Photodynamic Therapy in the Endoplasmic Reticulum
  69. Dural lymphatics regulate clearance of extracellular tau from the CNS
  70. Electrospray Functionalization of Titanium Dioxide Nanoparticles with Transferrin for Cerenkov Radiation Induced Cancer Therapy
  71. Shape-Dependent Biodistribution of Biocompatible Silk Microcapsules
  72. 3D Printing of Poloxamer 407 Nanogel Discs and Their Applications in Adjuvant Ovarian Cancer Therapy
  73. Calcium Carbonate Nanoparticles Stimulate Tumor Metabolic Reprogramming and Modulate Tumor Metastasis
  74. Preface
  75. Metal‐Organic Framework Encapsulation Preserves the Bioactivity of Protein Therapeutics
  76. Perspective review of what is needed for molecular-specific fluorescence-guided surgery
  77. Cellular Trafficking of Sn-2 Phosphatidylcholine Prodrugs Studied with Fluorescence Lifetime Imaging and Super-resolution Microscopy
  78. Reply to ‘Is Cherenkov luminescence bright enough for photodynamic therapy?’
  79. Nanotherapeutics for multiple myeloma
  80. Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with 18F-FDOPA and 18F-FDG PET
  81. Targeting CXCR4–CXCL12 Axis for Visualizing, Predicting, and Inhibiting Breast Cancer Metastasis with Theranostic AMD3100–Ag2S Quantum Dot Probe
  82. Bio-inspired imager improves sensitivity in near-infrared fluorescence image-guided surgery
  83. Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
  84. An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
  85. Dual-radiolabeled nanoparticle probes for depth-independent in vivo imaging of enzyme activation
  86. Effect of linkers on the αvβ3 integrin targeting efficiency of cyclic RGD-conjugates.
  87. Ultrasmall visible-to-near-infrared emitting silver-sulfide quantum dots for cancer detection and imaging
  88. Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer
  89. FOREWORD
  90. Perfusion‐based fluorescence imaging method delineates diverse organs and identifies multifocal tumors using generic near‐infrared molecular probes
  91. Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system
  92. Diagnosis of LVAD Thrombus using a High-Avidity Fibrin-Specific 99mTc Probe
  93. Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma
  94. Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
  95. Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
  96. Preclinical Development of CD38-Targeted [89Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma
  97. Bolus injections of novel thrombogenic site-targeted fusion proteins comprising annexin-V and Kunitz protease inhibitors attenuate intimal hyperplasia after balloon angioplasty
  98. Hybrid TiO2–Ruthenium Nano‐photosensitizer Synergistically Produces Reactive Oxygen Species in both Hypoxic and Normoxic Conditions
  99. Hybrid TiO2–Ruthenium Nano‐photosensitizer Synergistically Produces Reactive Oxygen Species in both Hypoxic and Normoxic Conditions
  100. Multimodal fluorescence molecular imaging for in vivo characterization of skin cancer using endogenous and exogenous fluorophores
  101. Noninvasive depth estimation using tissue optical properties and a dual-wavelength fluorescent molecular probe in vivo
  102. Nanophotosensitive drugs for light-based cancer therapy: what does the future hold?
  103. Novel Injury Site Targeted Fusion Protein Comprising Annexin V and Kunitz Inhibitor Domains Ameliorates Ischemia-Reperfusion Injury and Promotes Survival of Ischemic Rat Abdominal Skin Flaps
  104. Optical See-Through Cancer Vision Goggles Enable Direct Patient Visualization and Real-Time Fluorescence-Guided Oncologic Surgery
  105. Enhancingin vivotumor boundary delineation with structured illumination fluorescence molecular imaging and spatial gradient mapping
  106. Extracellular pH Modulates Neuroendocrine Prostate Cancer Cell Metabolism and Susceptibility to the Mitochondrial Inhibitor Niclosamide
  107. Acidic extracellular pH of tumors induces octamer-binding transcription factor 4 expression in murine fibroblasts in vitro and in vivo
  108. Proof-of-Concept of Polymeric Sol-Gels in Multi-Drug Delivery and Intraoperative Image-Guided Surgery for Peritoneal Ovarian Cancer
  109. A 110 × 64 150 mW 28 frames/s integrated visible/near-infrared CMOS image sensor with dual exposure times for image guided surgery
  110. Selective Photonic Disinfection of Cell Culture Using a Visible Ultrashort Pulsed Laser
  111. Influence of Bone and Muscle Injuries on the Osteogenic Potential of Muscle Progenitors: Contribution of Tissue Environment to Heterotopic Ossification
  112. Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma
  113. Editorial: Nanoscale approaches for cancer diagnosis and treatment
  114. Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth in vivo
  115. Nano-CaCO3 as a pH sensitive theranostic platform
  116. Nano-antacids enhance pH neutralization beyond their bulk counterparts: synthesis and characterization
  117. 3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma
  118. Protonation and Trapping of a Small pH-Sensitive Near-Infrared Fluorescent Molecule in the Acidic Tumor Environment Delineate Diverse Tumors in Vivo
  119. Compact wearable dual-mode imaging system for real-time fluorescence image-guided surgery
  120. Binocular Goggle Augmented Imaging and Navigation System provides real-time fluorescence image guidance for tumor resection and sentinel lymph node mapping
  121. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells
  122. Molecular Probes for Fluorescence Lifetime Imaging
  123. A compact NIR fluorescence imaging system with goggle display for intraoperative guidance
  124. Live demonstration: A compact NIR fluorescence imaging system design with goggle display for intraoperative guidance
  125. Utilizing the Multiradionuclide Resolving Power of SPECT and Dual Radiolabeled Single Molecules to Assess Treatment Response of Tumors
  126. Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers
  127. Performance comparison of different compact NIR fluorescent imaging systems with goggle display for intraoperative image-guidance
  128. Image overlay solution based on threshold detection for a compact near infrared fluorescence goggle system
  129. Tunable Ultrasmall Visible-to-Extended Near-Infrared Emitting Silver Sulfide Quantum Dots for Integrin-Targeted Cancer Imaging
  130. Dual-radiolabeled nanoparticle SPECT probes for bioimaging
  131. Small Sized EGFR1 and HER2 Specific Bifunctional Antibody for Targeted Cancer Therapy
  132. Visualization of pulmonary clearance mechanisms via noninvasive optical imaging validated by near‐infrared flow cytometry
  133. Foreword:
  134. Trimodal color-fluorescence-polarization endoscopy aided by a tumor selective molecular probe accurately detects flat lesions in colitis-associated cancer
  135. Errata: Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography
  136. Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment
  137. Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography
  138. Pathogen Reduction in Human Plasma Using an Ultrashort Pulsed Laser
  139. Quantum dots based molecular beacons for in vitro and in vivo detection of MMP-2 on tumor
  140. Bioinspired Polarization Imaging Sensors: From Circuits and Optics to Signal Processing Algorithms and Biomedical Applications
  141. Monitoring of Biodistribution and Persistence of Conditionally Replicative Adenovirus in a Murine Model of Ovarian Cancer Using Capsid-Incorporated mCherry and Expression of Human Somatostatin Receptor Subtype 2 Gene
  142. Ultrashort pulsed laser treatment inactivates viruses by inhibiting viral replication and transcription in the host nucleus
  143. Somatostatin Analogues for Receptor Targeted Photodynamic Therapy
  144. Engineering light-emitting diode surgical light for near-infrared fluorescence image-guided surgical systems
  145. Dual-mode optical imaging system for fluorescence image-guided surgery
  146. Antibody Quantum Dot Conjugates Developed via Copper-Free Click Chemistry for Rapid Analysis of Biological Samples Using a Microfluidic Microsphere Array System
  147. A dual-targeting nanocarrier based on modified chitosan micelles for tumor imaging and therapy
  148. Synthesis of dye conjugates to visualize the cancer cells using fluorescence microscopy
  149. Intravenous Application of CD271-selected Mesenchymal Stem Cells During Fracture Healing
  150. Tryptophan as the fingerprint for distinguishing aggressiveness among breast cancer cell lines using native fluorescence spectroscopy
  151. Tryptophan content for monitoring breast cancer cell aggressiveness by native fluorescence spectroscopy
  152. Community detection for fluorescent lifetime microscopy image segmentation
  153. Near infrared fluorescence quenching properties of copper (II) ions for potential applications in biological imaging
  154. Intraoperative imaging and fluorescence image guidance in oncologic surgery using a wearable fluorescence goggle system
  155. Quantitative determination of maximal imaging depth in all-NIR multiphoton microscopy images of thick tissues
  156. Therapeutic effect of the treatment for colorectal cancer with adenoviral vectors mediated estrogen receptor β gene therapy combined with thermotherapy
  157. Studies of inactivation mechanism of non-enveloped icosahedral virus by a visible ultrashort pulsed laser
  158. Highly luminescent water-soluble quaternary Zn–Ag–In–S quantum dots and their unique precursor S/In ratio-dependent spectral shifts
  159. Ultrabright NIR fluorescent mesoporous silica nanoparticles
  160. Drug loaded multilayered gold nanorods for combined photothermal and chemotherapy
  161. Real-Time Fluorescence Image-Guided Oncologic Surgery
  162. Probing Distance‐Dependent Plasmon‐Enhanced Near‐Infrared Fluorescence Using Polyelectrolyte Multilayers as Dielectric Spacers
  163. Dynamic optical projection of acquired luminescence for aiding oncologic surgery
  164. Automatic segmentation of fluorescence lifetime microscopy images of cells using multiresolution community detection—a first study
  165. First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent: a pilot study
  166. Gold nanoparticles based molecular beacons for in vitro and in vivo detection of the matriptase expression on tumor
  167. Special Section Guest Editorial: Special Section on Fluorescence Molecular Imaging Honoring Prof. Roger Tsien, a Pioneer in Biomedical Optics
  168. All-near-infrared multiphoton microscopy interrogates intact tissues at deeper imaging depths than conventional single- and two-photon near-infrared excitation microscopes
  169. Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels
  170. Activatable Probes Based on Distance‐Dependent Luminescence Associated with Cerenkov Radiation
  171. Near-infrared fluorescence goggle system with complementary metal–oxide–semiconductor imaging sensor and see-through display
  172. Dual fluorescent molecular substrates selectively report the activation, sustainability and reversibility of cellular PKB/Akt activity
  173. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery
  174. Bloodstain age analysis: toward solid state fluorescent lifetime measurements
  175. Investigation of native fluorescence spectral difference among prostate cancer cell lines with different risk levels
  176. Time-resolved fluorescence for breast cancer detection using an octreotate-indocyanine green derivative dye conjugate
  177. Microfluidic microsphere-trap arrays for simultaneous detection of multiple targets
  178. Near infrared spectral polarization imaging of prostate cancer tissues using Cybesin: a receptor-targeted contrast agent
  179. Performance Analysis and Design of Position-Encoded Microsphere Arrays Using the Ziv-Zakai Bound
  180. Visual detection of STAT5B gene expression in living cell using the hairpin DNA modified gold nanoparticle beacon
  181. Multimodal Fluorescence-Mediated Tomography and SPECT/CT for Small-Animal Imaging
  182. Synthesize dye-bioconjugates to visualize cancer cells using fluorescence microscopy
  183. Near-infrared light-triggered dissociation of block copolymer micelles for controlled drug release
  184. Docosahexaenoic acid conjugated near infrared flourescence probe for in vivo early tumor diagnosis
  185. MUC1 aptamer based near infrared fluorescence probes for tumor diagnosis
  186. Intraoperative detection of liver tumors aided by a fluorescence goggle system and multimodal imaging
  187. Highly luminescent water-soluble quaternary Zn–Ag–In–S quantum dots for tumor cell-targeted imaging
  188. Imaging mRNA expression levels in living cells with PNA·DNA binary FRET probes delivered by cationic shell-crosslinked nanoparticles
  189. Sensitivity of activatable reactive oxygen species probes by fluorescence spectroelectrochemistry
  190. Broad spectrum photoluminescent quaternary quantum dots for cell and animal imaging
  191. Blood triggered rapid release porous nanocapsules
  192. Click reaction-mediated functionalization of near-infrared pyrrolopyrrole cyanine dyes for biological imaging applications
  193. Multifunctional Gold Nanostar Conjugates for Tumor Imaging and Combined Photothermal and Chemo-therapy
  194. In Vivo Targeted Deep-Tissue Photodynamic Therapy Based on Near-Infrared Light Triggered Upconversion Nanoconstruct
  195. Pyrazole‐substituted Near‐infrared Cyanine Dyes Exhibit pH‐dependent Fluorescence Lifetime Properties
  196. Inactivation of enveloped virus by laser-driven protein aggregation
  197. Complementary fluorescence-polarization microscopy using division-of-focal-plane polarization imaging sensor
  198. Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies
  199. Near-infrared fluorescent divalent RGD ligand for integrin αvβ3-targeted optical imaging
  200. Rapid response activatable molecular probes for intraoperative optical image-guided tumor resection
  201. High-Quality CuInS2/ZnS Quantum Dots for In vitro and In vivo Bioimaging
  202. NIR Fluorophore-Hollow Gold Nanosphere Complex for Cancer Enzyme-Triggered Detection and Hyperthermia
  203. Fluorescence lifetime imaging microscopy using near‐infrared contrast agents
  204. In vitro and in vivo evaluation of a 64Cu-labeled NOTA-Bn-SCN-Aoc-bombesin analogue in gastrin-releasing peptide receptor expressing prostate cancer
  205. Matriptase Sensitive Gold Nanoparticle Probe for early Cancer Detection
  206. Comparison of near‐infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivo
  207. Inhibitory effects of ERβ on proliferation, invasion, and tumor formation of MCF-7 breast cancer cells-prognostication for the use of ERβ-selective therapy
  208. The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression
  209. Near‐Infrared Molecular Probes for In Vivo Imaging
  210. Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells
  211. Multimodal sentinel lymph node mapping with single-photon emission computed tomography (SPECT)/computed tomography (CT) and photoacoustic tomography
  212. Detection of MMP-2 and MMP-9 Activity in Vivo with a Triple-Helical Peptide Optical Probe
  213. Induction of pH Sensitivity on the Fluorescence Lifetime of Quantum Dots by NIR Fluorescent Dyes
  214. In Vivo Fluorescence Lifetime Imaging Monitors Binding of Specific Probes to Cancer Biomarkers
  215. Fluorescence goggle for intraoperative breast cancer imaging
  216. Fluorophore–gold nanoparticle complex for sensitive optical biosensing and imaging
  217. Multi-modal in cellulo evaluation of NPR-C targeted C-ANF-peptide and C-ANF-comb nanoparticles
  218. Screening prostate cancer using a portable near infrared scanning imaging unit with an optical fiber-based rectal probe
  219. Time-domain imaging with quench-based fluorescent contrast agents
  220. Defining a Polymethine Dye for Fluorescence Anisotropy Applications in the Near‐Infrared Spectral Range
  221. Preclinical evaluation of Mab CC188 for ovarian cancer imaging
  222. Dating Bloodstains with Fluorescence Lifetime Measurements
  223. Synthesis of NAC capped near infrared-emitting CdTeS alloyed quantum dots and application for in vivo early tumor imaging
  224. A NIR dye for development of peripheral nerve targeted probes
  225. Amphiphilic chitosan modified upconversion nanoparticles for in vivo photodynamic therapy induced by near-infrared light
  226. Glucosamine derivative modified nanostructured lipid carriers for targeted tumor delivery
  227. Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy
  228. A paclitaxel-conjugated adenovirus vector for targeted drug delivery for tumor therapy
  229. Near Infrared Photonic Finger Imager for Prostate Cancer Screening
  230. Using In-Vivo Fluorescence Imaging in Personalized Cancer Diagnostics and Therapy, an Image and Treat Paradigm
  231. Video-rate fluorescence diffuse optical tomography for in vivo sentinel lymph node imaging
  232. Sensitivity Enhancement of NIR Fluorescence Contrast Agent Utilizing Gold Nanoparticles
  233. Glucosamine-Linked Near-Infrared Fluorescent Probes for Imaging of Solid Tumor Xenografts
  234. Two-Photon Optical Properties of Near-Infrared Dyes at 1.55 μm Excitation
  235. Gold nanoparticle–fluorophore complex for conditionally fluorescing signal mediator
  236. Single step aerosol synthesis of nanocomposites by aerosol routes: γ-Fe2O3/SiO2 and their functionalization
  237. Hands-free, wireless goggles for near-infrared fluorescence and real-time image-guided surgery
  238. Exploring new near-infrared fluorescent disulfide-based cyclic RGD peptide analogs for potential integrin-targeted optical imaging
  239. Near-Infrared Fluorescence Lifetime pH-Sensitive Probes
  240. Study of rotational dynamics of receptor-targeted contrast agents in cancerous and normal prostate tissues using time-resolved picosecond emission spectroscopy
  241. Improved Targeting of Ligand-Modified Adenovirus as a New Near Infrared Fluorescence Tumor Imaging Probe
  242. Near-Infrared pH-Activatable Fluorescent Probes for Imaging Primary and Metastatic Breast Tumors
  243. Rational Approach To Select Small Peptide Molecular Probes Labeled with Fluorescent Cyanine Dyes for in Vivo Optical Imaging
  244. In Vitro and In Vivo Evaluation of 64Cu-Labeled SarAr-Bombesin Analogs in Gastrin-Releasing Peptide Receptor–Expressing Prostate Cancer
  245. Compact intraoperative imaging device for sentinel lymph node mapping
  246. Novel design of multimodal MRI/NIR optical contrast agent
  247. Photoacoustic image-guided needle biopsy of sentinel lymph nodes
  248. Time-resolved spectroscopy and near infrared imaging enhanced by receptor-targeted contrast agents for prostate cancer detection
  249. Gold nanocages covered with thermally-responsive polymers for controlled release by high-intensity focused ultrasound
  250. Detection of enzyme activity in orthotopic murine breast cancer by fluorescence lifetime imaging using a fluorescence resonance energy transfer–based molecular probe
  251. Fluorescence Manipulation by Gold Nanoparticles: From Complete Quenching to Extensive Enhancement
  252. Highly Specific, NIR Fluorescent Contrast Agent with Emission Controlled by Gold Nanoparticle
  253. Optical Imaging in Cancer Research: Basic Principles, Tumor Detection, and Therapeutic Monitoring
  254. Synthesis and spectroscopy of near infrared fluorescent dyes for investigating dichromic fluorescence
  255. Noninvasive Photoacoustic and Fluorescence Sentinel Lymph Node Identification using Dye-Loaded Perfluorocarbon Nanoparticles
  256. The Insatiable Quest for Near‐Infrared Fluorescent Probes for Molecular Imaging
  257. Perspectives and potential applications of nanomedicine in breast and prostate cancer
  258. Measurement of the binding parameters of annexin derivative–erythrocyte membrane interactions
  259. Multimodality Imaging of Gene Transfer with a Receptor-Based Reporter Gene
  260. MAb L9E10 to Blood Group H2 Antigen Binds to Colon Cancer Stem Cells and Inhibits Tumor Cell Migration and Invasion
  261. Monoclonal Antibody L9E10 to Blood Group H2 Antigen
  262. Handheld array-based photoacoustic probe for guiding needle biopsy of sentinel lymph nodes
  263. Targeting of α ν β 3 -Integrins Expressed on Tumor Tissue and Neovasculature Using Fluorescent Small Molecules and Nanoparticles
  264. Introduction to Concepts and Strategies for Molecular Imaging
  265. Folate-Polyethylene Glycol Conjugated Near-Infrared Fluorescence Probe with High Targeting Affinity and Sensitivity for In Vivo Early Tumor Diagnosis
  266. Fluorescence Lifetime Measurements and Biological Imaging
  267. Near-infrared molecular imaging probes based on chlorin-bacteriochlorin dyads
  268. Biological applications of fluorescence lifetime imaging beyond microscopy
  269. In vivo investigation of pharmacokinetics of model drug: comparison of near infrared technique with high-performance liquid chromatography
  270. Multimodal nonlinear microscopy at 1.5 µm
  271. Rotational dynamics and polarization anisotropy of bound and unbound receptor-targeted contrast agents in cancerous and normal prostate tissues studied by time-resolved fluorescence spectroscopy
  272. Strategies for developing pH sensitive fluorescent probes
  273. Understanding dichromic fluorescence manifested in certain indocyanine green (ICG) analogs
  274. Near infrared-fluorescent and magnetic resonance imaging molecular probe with high T1 relaxivity for in vivo multimodal imaging
  275. Bright fluorescent nanoparticles for developing potential optical imaging contrast agents
  276. Multiphoton microscopy with near infrared contrast agents
  277. Synthesis of functional near infrared pyrrolopyrrole cyanine dyes for optical and photoacoustic imaging
  278. Optical Imaging of Mammary and Prostate Tumors in Living Animals using a Synthetic Near Infrared Zinc(II)-Dipicolylamine Probe for Anionic Cell Surfaces
  279. Long Fluorescence Lifetime Molecular Probes Based on Near Infrared Pyrrolopyrrole Cyanine Fluorophores for In Vivo Imaging
  280. FRET-Like Fluorophore-Nanoparticle Complex for Highly Specific Cancer Localization
  281. Engineering NIR dyes for fluorescent lifetime contrast
  282. Radioactivity-Synchronized Fluorescence Enhancement Using a Radionuclide Fluorescence-Quenched Dye
  283. 64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity
  284. pH‐Dependent Optical Properties of Synthetic Fluorescent Imidazoles
  285. Dynamic noninvasive monitoring of renal function in vivo by fluorescence lifetime imaging
  286. Multimodal Imaging of Integrin Receptor-Positive Tumors by Bioluminescence, Fluorescence, Gamma Scintigraphy, and Single-Photon Emission Computed Tomography Using a Cyclic RGD Peptide Labeled with a Near-Infrared Fluorescent Dye and a Radionuclide
  287. Characterization of quenched fluorescent triple helical peptides for MMP-2 and MMP-9 optical imaging
  288. In vivo imaging with near-infrared fluorescence lifetime contrast
  289. Activatable Molecular Systems Using Homologous Near-Infrared Fluorescent Probes for Monitoring Enzyme Activitiesin Vitro,in Cellulo, andin Vivo
  290. Complementary optical and nuclear imaging of caspase-3 activity using combined activatable and radio-labeled multimodality molecular probe
  291. In vivo fluorescence lifetime tomography
  292. Modulation of Effector Caspase Cleavage Determines Response of Breast and Lung Tumor Cell Lines to Chemotherapy
  293. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration
  294. Time-resolved fluorescence polarization of cancer receptor-targeted contrast agents in prostate tissues
  295. Near-Infrared Fluorescent pH-Sensitive Probes via Unexpected Barbituric Acid Mediated Synthesis
  296. Fluorescence lifetime properties of near-infrared cyanine dyes in relation to their structures
  297. Monoclonal Antibody CC188 Binds a Carbohydrate Epitope Expressed on the Surface of Both Colorectal Cancer Stem Cells and their Differentiated Progeny
  298. Multimodal optical-nuclear molecular imaging of tumors
  299. Monitoring the Biodegradation of Dendritic Near-Infrared Nanoprobes by in Vivo Fluorescence Imaging
  300. Preparation and Biological Evaluation of 64Cu-CB-TE2A-sst2-ANT, a Somatostatin Antagonist for PET Imaging of Somatostatin Receptor–Positive Tumors
  301. Differential Activity of Caspase-3 Regulates Susceptibility of Lung and Breast Tumor Cell Lines to Paclitaxel
  302. Neutrophil Elastase Mediates Innate Host Protection against Pseudomonas aeruginosa
  303. Optimization of the Near-Infrared Fluorescence Labeling for In Vivo Monitoring of a Protein Drug Distribution in Animal Model
  304. Time-resolved fluorescence polarization dynamics and optical imaging of Cytate: a prostate cancer receptor-targeted contrast agent
  305. Near‐Infrared Dichromic Fluorescent Carbocyanine Molecules
  306. Fluorescent lifetime of near infrared dyes for structural analysis of serum albumin
  307. Multimodality Molecular Imaging with Combined Optical and SPECT/PET Modalities: TABLE 1
  308. Predicting in vivo fluorescence lifetime behavior of near-infrared fluorescent contrast agents using in vitro measurements
  309. Synthesis and Spectral Properties of Near-Infrared Aminophenyl-, Hydroxyphenyl-, and Phenyl-Substituted Heptamethine Cyanines
  310. Biodegradable pH-Sensing Dendritic Nanoprobes for Near-Infrared Fluorescence Lifetime and Intensity Imaging
  311. Novel optical contrast agents containing both DFO and multi-RGD peptides
  312. Novel Near-Infrared Fluorescent Integrin-Targeted DFO Analogue
  313. Agonist−Antagonist Dilemma in Molecular Imaging: Evaluation of a Monomolecular Multimodal Imaging Agent for the Somatostatin Receptor
  314. Near Infrared Dyes as Lifetime Solvatochromic Probes for Micropolarity Measurements of Biological Systems
  315. Unravelling animal anatomy
  316. Ratiometric Analysis of Fluorescence Lifetime for Probing Binding Sites in Albumin with Near‐Infrared Fluorescent Molecular Probes
  317. In Vivo Resolution of Multiexponential Decays of Multiple Near-Infrared Molecular Probes by Fluorescence Lifetime-Gated Whole-Body Time-Resolved Diffuse Optical Imaging
  318. Time-resolved fluorescence polarization anisotropy and optical imaging of Cybesin in cancerous and normal prostate tissues
  319. Modulation of nuclear internalization of Tat peptides by fluorescent dyes and receptor‐avid peptides
  320. Molecular Modeling Suggests Conformational Scaffolds Specifically Targeting Five Subtypes of Somatostatin Receptors
  321. In vivo resolution of two near-infrared fluorophores by time-domain diffuse optical tomagraphy
  322. Novel synthon for incorporating 1,3-dimethyl-imidazolium group into molecular architecture
  323. Heptamethine Cyanine Dyes with a Robust C−C Bond at the Central Position of the Chromophore
  324. Targeting Beta-3 Integrin Using a Linear Hexapeptide Labeled with a Near-Infrared Fluorescent Molecular Probe
  325. Quantitative small animal fluorescence tomography using an ultra-fast gated image intensifier
  326. Design, Synthesis, and Evaluation of Near Infrared Fluorescent Multimeric RGD Peptides for Targeting Tumors
  327. Design, synthesis, and evaluation of near-infrared fluorescent pH indicators at physiological range
  328. Internalization of RGD peptide conjugates of near-infrared fluorescent probes in different cell lines occurs via different integrin receptor subtypes
  329. Preliminary study on the inhibition of nuclear internalization of Tat peptides by conjugation with a receptor-specific peptide and fluorescent dyes
  330. Synthesis and evaluation of two NIR fluorescent cyclic RGD penta-peptides for targeting integrins
  331. Synthesis, metal coordination, and cellular internalization of a siderophore-bearing NIR fluorescent carbocyanine probe
  332. In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models
  333. Spectral Properties of Pro‐multimodal Imaging Agents Derived from a NIR Dye and a Metal Chelator
  334. A Novel Approach to a Bifunctional Photosensitizer for Tumor Imaging and Phototherapy
  335. Monomolecular Multimodal Fluorescence-Radioisotope Imaging Agents
  336. Spectral Polarization Imaging of Human Prostate Cancer Tissue Using a Near-infrared Receptor-targeted Contrast Agent
  337. Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression
  338. Design, synthesis and evaluation of near-infrared fluorescent pH indicators in a physiologically relevant range
  339. Fast Scanning Fluorescence Optical Tomography for Small Animal Whole Body Biodistribution Assays
  340. Chemical and Genetic Sensors in Biomedical Research
  341. Time-dependent whole-body fluorescence tomography of probe bio-distributions in mice
  342. Whole-body fluorescence lifetime imaging of a tumor-targeted near-infrared molecular probe in mice
  343. Multivalent Carbocyanine Molecular Probes:  Synthesis and Applications
  344. Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator
  345. Optical Imaging Agents and Potential Application in the Assessment of Pancreatic Beta Cells
  346. <title>Imaging of tumor hypermetabolism with near-infrared fluorescence contrast agents</title>
  347. Lighting up Tumors with Receptor-Specific Optical Molecular Probes
  348. Synthesis and evaluation of novel galactose-carbocyanine fluorescent contrast agents with enhanced hydrophilicity and rigid molecular constraint
  349. Targeting the expression of integrin receptors in tumors
  350. Polyvalent Carbocyanine Molecular Beacons for Molecular Recognitions
  351. Metabolism-enhanced tumor localization by fluorescence imaging: in vivo animal studies
  352. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells
  353. Determination of subsurface tumor localization in animal models with near-infrared (NIR) fluorescence imaging
  354. Novel Bioactive and Stable Neurotensin Peptide Analogues Capable of Delivering Radiopharmaceuticals and Molecular Beacons to Tumors
  355. Synthesis and Characterization of a Macrocyclic Near-Infrared Optical Scaffold
  356. Small animal imaging
  357. Phase cancellation system for tumor imaging using targeted fluorescent contrast agents
  358. Synthesis, In Vitro Receptor Binding, and In Vivo Evaluation of Fluorescein and Carbocyanine Peptide-Based Optical Contrast Agents
  359. <title>New approach to optical imaging of tumors</title>
  360. <title>Targeted Type 1 phototherapeutic agents using azido-peptide bioconjugates</title>
  361. <title>Site-specific tumor-targeted fluorescent contrast agents</title>
  362. Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform
  363. Novel Receptor-Targeted Fluorescent Contrast Agents for In Vivo Tumor Imaging
  364. A New Method for the Synthesis of Tri-tert-butyl Diethylenetriaminepentaacetic Acid and Its Derivatives
  365. Stabilization of the Optical Tracer Agent Indocyanine Green Using Noncovalent Interactions
  366. Preparation and Antibiotic Activity of Monobactam Analogues of Nocardicins
  367. Bioactive surfactants containing a β-lactam group: synthesis and properties
  368. Synthesis and evaluation of the properties of fluorinated amphiphilic amides of 2,2-bis(hydroxymethyl)propionic acid
  369. Synthesis of monodisperse perfluoroalkyl–oxyethylene surfactants with methoxy capping: surfactants of high chemical inertness